PCI Biotech awarded NOK 13.8 million from The Research Council of Norway to further development of PCI for use in vaccination NewsRonny SkuggedalJanuary 27, 2017
The PCI Biotech and Ultimovacs collaboration awarded NOK 500,000 from Innovation Norway NewsRonny SkuggedalJanuary 6, 2017
Mandatory notification regarding exercise and trade of subscription rights and trade of shares NewsRonny SkuggedalDecember 21, 2016
Update on the existing pre-clinical research collaboration agreement with a top-10 large pharma company NewsRonny SkuggedalDecember 13, 2016
PCI Biotech and eTheRNA immunotherapies initiate research collaboration NewsRonny SkuggedalDecember 8, 2016
Notice to the extraordinary general meeting to resolve a fully underwritten Rights Issue of NOK 70 million NewsRonny SkuggedalNovember 17, 2016
PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 70 million NewsRonny SkuggedalNovember 17, 2016
PCI Biotech to present poster at the ESMO Symposium on Immuno-Oncology 2016 NewsRonny SkuggedalNovember 4, 2016
